Bottom line
What is PHYMX's expense ratio?
PHYMX's expense ratio is 1.24%, or about $124 a year on every $10,000 invested. That is more expensive than 84% of high-yield bond funds we track (median 0.74%). This share class also charges a front-end sales load of up to 3.25%, taken from your investment when you buy. Its expense ratio includes a 0.5% 12b-1 marketing fee.
Updated Mar 25, 2026
PHYMX fee table
| Net expense ratio | 1.24% |
|---|---|
| Gross expense ratio | 1.24% |
| Management fee | 0.54% |
| 12b-1 (distribution) fee | 0.5% |
| Other expenses | 0.2% |
| Max front-end sales load | 3.25% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Mar 25, 2026
What PHYMX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| PHYMX | $447 | $706 | $985 | $1,777 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.24% expense ratio costs roughly $67,300 in lost growth, versus about $41,900 for the median high-yield bond fund (0.74%).